Integrated Dissolution Solution for R&D and QC Labs

News
Article

Pharmaceutical Technology's In the Lab eNewsletter

In the Lab eNewsletterPharmaceutical Technology\'s In the Lab eNewsletter-06-07-2018
Volume 13
Issue 6

Mettler Toledo and SOTAX partnered to develop a new dissolution solution system line for R&D and quality control laboratory processes.

Mettler Toledo and SOTAX, a Switzerland-based manufacturer of dissolution testing equipment of pharmaceutical dosage forms, have partnered to develop a new dissolution system line for R&D and quality control laboratory processes.

The system is based on Mettler Toledo’s UV7 Excellence spectrophotometer integrated with the SOTAX Xtend dissolution line. The joint solution can meet a range of needs, including manual operations and fully automated processes. According to Mettler, the various Xtend modules combined with the UV7, CuvetteChanger, and automatic optical performance verification CertiRef allow for seamless ultraviolet-visible spectroscopy (UV/VIS) measurement integration. Automatic sampling and analyses at predefined intervals can be achieved in real time without operator intervention. 

The spectrophotometer FastTrack array technology provides instant measurement readiness, rapid delivery of results, and maximized compactness to optimize bench space, Mettler reports. The modular design of the instrument incorporates a selection of easily connected automation accessories. The CertiRef module, which renders the instrument fully compliant with United States Pharmacopeia and European Pharmacopeia regulations, allows the required optical performance tests to be integrated into the analytical workflow. These tests are automatically executed and traceably documented. For maximal automation requirements, the CuvetteChanger offers efficient sample handling for up to eight cuvette positions. 

Source: Mettler Toledo

Recent Videos
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content